Australia markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.6196-0.0004 (-0.02%)
As of 12:10PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7775
Avg. Estimate0.02-0.2-0.440.04
Low estimate-0.31-0.25-1-0.67
High estimate0.46-0.140.091.49
Year ago EPS-0.79-0.46-2.03-0.44
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7775
Avg. Estimate77.15M42.18M257.73M382.44M
Low estimate28.9M38M174M266.1M
High estimate144.57M50.66M328.2M710.2M
Year ago sales24.33M25.79M116.33M257.73M
Sales growth (year/est)217.10%63.60%121.50%48.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.65-0.61-0.43-0.48
Actual EPS-0.79-0.46-0.37-0.5
Difference-0.140.150.06-0.02
Surprise %-21.50%24.60%14.00%-4.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.02-0.2-0.440.04
7 days ago0.01-0.21-0.440.2
30 days ago-0.040.1-0.280.51
60 days ago-0.070.06-0.340.33
90 days ago-0.380.07-0.030.28
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A11
Growth estimatesESPRIndustrySector(s)S&P 500
Current qtr.102.50%N/AN/AN/A
Next qtr.56.50%N/AN/AN/A
Current year78.30%N/AN/AN/A
Next year109.10%N/AN/AN/A
Next 5 years (per annum)16.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A